Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us ![]()
About
International Sweetene...International Sweetener Colloquium
Not Confirmed
Not Confirmed
22-25 February, 2026
Not Confirmed
Not Confirmed
23-25 February, 2026
Clinical Trial Supply ...Clinical Trial Supply Europe
Not Confirmed
Not Confirmed
24-25 February, 2026
List your booth number for exhibitions, ask us
CONTACT DETAILS




Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
International Sweetene...International Sweetener Colloquium
Industry Trade Show
Not Confirmed
22-25 February, 2026
Industry Trade Show
Not Confirmed
23-25 February, 2026
Clinical Trial Supply ...Clinical Trial Supply Europe
Industry Trade Show
Not Confirmed
24-25 February, 2026
Digital content

19 Feb 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/02/19/3241544/0/en/Candel-Therapeutics-Announces-Proposed-100-Million-Public-Offering.html

02 Feb 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/02/02/3230605/0/en/Candel-Therapeutics-Announces-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html

17 Nov 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/11/17/3189579/0/en/Candel-Therapeutics-to-Host-Virtual-R-D-Event-on-December-5-2025.html

13 Nov 2025
// FIERCE BIOTECH
https://www.fiercebiotech.com/biotech/century-candel-and-macrogenics-call-time-certain-clinical-trials-conserve-cash

13 Nov 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/11/13/3187333/0/en/Candel-Therapeutics-Reports-Third-Quarter-2025-Financial-Results-and-Recent-Corporate-Highlights.html

04 Nov 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/11/04/3180386/0/en/Candel-Therapeutics-Showcases-Immunotherapy-Leadership-at-SITC-2025-Demonstrating-Integration-of-Clinical-Innovation-Multi-Omics-and-Artificial-Intelligence-to-Advance-Next-Generat.html
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE